Related Experiment Videos
Permanent mechanical replacement of the left ventricle
1Cullen Cardiovascular Research Laboratories, Texas Heart Institute, Houston, USA.
Cardiology Clinics
|February 1, 1995
Summary
Congestive heart failure patients can have improved outcomes with the HeartMate left ventricular assist device. This device may prolong life, enhance quality of life, and reduce healthcare costs for patients.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
Background:
- Congestive heart failure (CHF) is associated with poor patient prognosis and high healthcare expenditures.
- Current treatment options for advanced CHF are limited and often invasive.
Purpose of the Study:
- To evaluate the impact of the HeartMate left ventricular assist device (LVAD) on patients with congestive heart failure.
- To assess the potential of LVADs as a long-term therapeutic option for CHF.
Main Methods:
- The study involved patients treated with the HeartMate LVAD.
- Outcomes assessed included survival, quality of life, and cost of care.
Main Results:
- Treatment with the HeartMate LVAD demonstrated prolonged survival for CHF patients.
- Patients experienced increased quality of life and decreased cost of care.
- The device is currently approved as a bridge to transplantation.
Conclusions:
- The HeartMate LVAD offers significant benefits for patients with congestive heart failure.
- LVADs show promise for permanent left ventricular support as an alternative to cardiac transplantation.